Navigation Links
Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
Date:5/23/2008

In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers

who are quitting smoking

PITTSBURGH, May 23 /PRNewswire/ -- With the Federal Aviation Administration's (FAA) recent announcement to remove a prescription anti-smoking pill from their approved list of safe medications for pilots, GSK Consumer Healthcare, an industry leader in smoking cessation, is offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all licensed commercial and private pilots who are interested in quitting smoking today, through June 30. It is important for pilots to understand that NRT has been the recommended aid for pilots to quit smoking since 1994, and that the FAA news in no way includes GSK's products, which are deemed safe and effective medicines to relieve nicotine withdrawal symptoms that arise during a quit attempt.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gsk/33419/

Recent clinical research has demonstrated that the Commit 4 mg lozenge reverses the negative impact that nicotine withdrawal has on the ability to concentrate, attention deficit, short-term memory and selective attention during a quit attempt(1) -- all these issues were at the core of the FAA's ruling.

"It's important that pilots interested in quitting have access to safe, evidence-based treatments," said Bill Slivka, vice president, Smoking Control, GlaxoSmithKline Consumer Healthcare. "Over the past ten years, our NRT products, including the Commit lozenge, have helped more than 6.5 million smokers around the world quit. This free offer to pilots and air traffic controllers further demonstrates our mission to help more smokers achieve their goal of safely becoming smoke-free."

The Commit lozenge give-away program is open to all U.S. residents,
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...ACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswi...nthegreaterLongBeachareathankstoFaithInAction/Volu...atHome(IAH),adivisionofSCANHealthPlan.Formorethan1...nteerstodeliverwarmThanksgivingmealstoseniorsinnee...Angelesandsurroundingcities. ,, "Ourwarmholiday...
(Date:11/25/2009)...rvivors of testicular cancer who were treated with... effects, including neurological side effects and ...ted with chemotherapy, according to a new study pu...National Cancer Institute . , Marianne Brydy, M....rsity Hospital, in Bergen, Norway, and colleagues ...
(Date:11/25/2009)...eady used to fight rheumatoid arthritis, could hel... , WEDNESDAY, Nov. 25 (HealthDay News) -- A drug... rheumatoid arthritis now also shows some promise ...abetes. , The drug, rituximab (Rituxan), helped..., even though the disease had destroyed some of th...
(Date:11/25/2009)...K,Nov.25/PRNewswire/-- MISSIONSkincare ®ispro...St.Jude.AspartofGNC,sannualSt.Jude ThanksandGiving...ncare,s new SUPER-C(TM)LipBalm willbedonatedtoSt...omakea$1,$5or$10donationatcheckoutatoneoftheir5,00...an$1millionforSt.Judeduringtheir2009 ThanksandGivi...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...RG, S.C., Feb. 10 Zeus, Inc. is pleased to introd...live and accessible via http://www.zeusinc.com . ... site is a user-friendly resource for comprehensiv...t of information into four categories listed on th...
..., Ill., Feb. 10 A prestigious panel of pain-manag...ty (APS) www.ampainsoc.org and the American Acad...t comprehensive clinical practice guideline to ass...rent issue of The Journal of Pain , www.jpain.or...
... Cambridge Healthtech Media Group,...ounced the launch of a new website devoted to excl... --www.ecliniqua.com. , N...website devoted to exclusive coverage of the clini...
...ts at the Institute for Myeloma and Bone Cancer Re...ould explain how blood vessels form within tumors....vered a new way that cancers orchestrate the produ...by tumor cells in multiple myeloma, a common form ...
...INGTON, Del., Feb. 10 Four western New York hospi...ing evidence-based therapy and,better communicatio... patient,deaths by 19 percent for up to one year a...Mortality in Patients,with Acute Coronary Syndrome...
...ARD, Calif., Feb. 10 Arete Therapeutics Inc. toda... trial for AR9281, an orally-,administered soluble...d for,the treatment of type 2 diabetes. S-EH is an... "Our AR9281 Phase II clinical trial program break...
Other Medicine News:Health News:New Guidelines for Prescribing Opioid Pain Drugs Published 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3Health News:Researchers Identify Novel Mechanism That Make Cancer Tumors Grow 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 4Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 2Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 3
(Date:11/24/2009)...ov.24/PRNewswire/-- EisaiInc.andPfizerIncannounce...acceptedforreviewEisai,sNewDrugApplication(NDA)for...ease)tabletsforthetreatmentofmoderatetosevereAlzhe...ains23mgofdonepezilHClinanextendedrelease,matrix-t...leaseofthedrug.TheNDAisbasedonahead-to-headclinica...
(Date:11/24/2009)...swire-FirstCall/--ThoratecCorporation(Nasdaq: THOR...supporttherapiestosave,supportandrestorefailinghea...ualPiperJaffrayHealthCareConferenceonTuesday,Decem...chieffinancialofficer,willprovideanupdateonthecomp...m.,PacificStandardTime). ,, Thepresentationwill...
(Date:11/24/2009)...re/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(...arch(NYSE: SI ),todayannouncedthatitsZargisCardios...BS, TheEarlyShow duringasegmentinwhichMarkJannot,t...ningproductsfromthepublication,s2009"BestofWhat,sN...evisionmorningnewstalkshowbroadcastbyCBSfromNewYor...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3MedAssurant to Support AHIPs Research Capabilities 57024 1MedAssurant to Support AHIPs Research Capabilities 57024 2Thoratec Presentation at UBS Conference to be Webcast 57022 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3
...INGSTON, N.J.--(BUSINESS WIRE)--Jun 25, 2007 - Col...today that an interim,analysis of a pregnancy stud...erone gel) to compounded intramuscular progesteron...l be published in,Fertility and Sterility, the jou...cine (ASRM)., This ongoing prospective randomized ...
...YMOUTH MEETING, Pa., June 25, 2007 /PRNewswire-Fir...t data from a preclinical,study of trodusquemine (...ted during the American Diabetes Association (ADA)...IL. Dr. Kristen Lantz,Genaera research scientist ...rodusquemine is a Multiple Pathway Inhibitor that,...
Other Medicine Technology:Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 2Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 3Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 4Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4
RGP OrthoK Lenses
... rigid gas permeable contact lenses used for corne...corrects nearsightedness (myopia). The patient wea... them upon wakening. During the day, nearsightedne...RT and Quadra RG contact lenses apply slight press...
...ware of the High Prevalence of Sleep Disordered Br...t Population?, , As Prevalent as Diabetes, with Va...OSA), the most common form of SDB, affects an esti...y 5% of the OSA patients have been diagnosed, leav...
... SP-9000 is exactly the same as the model SP-8800 ...separate Pachy mode. This mode has its own fixatio...directions. It allows you to select an area on the...t-in software to calculate averages of multiple re...
Medicine Products: